Suzuki Miho, Yoshimura Noh Jaeduk, Sugino Kiminori, Ito Koichi
Ito Hospital, Japan.
Intern Med. 2016;55(22):3309-3313. doi: 10.2169/internalmedicine.55.6980. Epub 2016 Nov 15.
A patient presented with hyperthyroidism and end-stage renal disease requiring hemodialysis that was difficult to control despite increased dosages of anti-thyroid drugs. The condition could finally be controlled by I radioactive iodine therapy (RIT) and hemodialysis provided under a hospital-linkage system. During three hemodialysis sessions after the oral administration of I, we measured the radioactivity released from the patient and the radioactivity of the devices/tools used. The radioactivity of the devices/tools was managed by allowing the isotope to decay into non-radioactive elements. Our experience suggests that outpatient RIT may provide a safe and convenient means of treating Graves' disease, even in patients receiving hemodialysis.
一名患有甲状腺功能亢进症和终末期肾病的患者需要进行血液透析，尽管增加了抗甲状腺药物的剂量，但病情仍难以控制。最终，通过放射性碘治疗（RIT）和在医院联动系统下提供的血液透析，病情得以控制。在口服碘后进行的三次血液透析过程中，我们测量了患者释放的放射性以及所用设备/工具的放射性。通过使同位素衰变为非放射性元素来管理设备/工具的放射性。我们的经验表明，门诊放射性碘治疗即使对于接受血液透析的患者，也可能是一种安全便捷的治疗格雷夫斯病的方法。
